Influx Healthtech Limited (NSE:INFLUX)
India flag India · Delayed Price · Currency is INR
275.50
-4.75 (-1.69%)
At close: Nov 16, 2026

Influx Healthtech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,6551,4681,049999.65760.57592.02
Revenue Growth
12.70%40.04%4.89%31.44%28.47%-
Gross Profit
644.06590.3409.05343.65231.94135.64
Operating Income
291.39261.17178.46151.2897.8660.48
Net Income
225.39205.39133.66111.2871.9644.37
Earnings Per Share
9.749.357.366.133.962.44
EPS Growth
4.21%27.01%20.06%54.80%62.00%-

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
151.45274.6519.1136.0635.4714.65
Total Debt
--2.193.257.996.1
Net Cash (Debt)
151.45274.6516.9132.8127.498.55
Net Cash Growth
-44.86%1523.82%-48.45%19.36%221.40%3766.52%
Net Cash Per Share
6.5512.500.931.811.510.47

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
98.2738.8770.5689.4368.2229.12
Capital Expenditures
-327.63-245.62-82.11-83.6-48.8-28.63
Free Cash Flow
-229.36-206.75-11.555.8319.430.49
Free Cash Flow Growth
----70.00%3856.82%-

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
38.92%40.20%39.01%34.38%30.50%22.91%
Operating Margin
17.61%17.79%17.02%15.13%12.87%10.22%
Pretax Margin
18.33%18.55%17.05%14.94%12.80%10.14%
Profit Margin
13.62%13.99%12.75%11.13%9.46%7.49%
FCF Margin
-13.86%-14.08%-1.10%0.58%2.55%0.08%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
28.2822.77----
PS Ratio
3.853.19----